Colorectal cancer: The facts in the case of the microbiota

The importance of the microbiota in the development of colorectal cancer (CRC) is increasingly evident, but identifying specific microbial features that influence CRC initiation and progression remains a central task for investigators. Studies determining the microbial mechanisms that directly contr...

Full description

Bibliographic Details
Main Authors: Clay, S.L (Author), Fonseca-Pereira, D. (Author), Garrett, W.S (Author)
Format: Article
Language:English
Published: American Society for Clinical Investigation 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 02940nam a2200541Ia 4500
001 10-1172-JCI155101
008 220420s2022 CNT 000 0 und d
020 |a 00219738 (ISSN) 
245 1 0 |a Colorectal cancer: The facts in the case of the microbiota 
260 0 |b American Society for Clinical Investigation  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1172/JCI155101 
520 3 |a The importance of the microbiota in the development of colorectal cancer (CRC) is increasingly evident, but identifying specific microbial features that influence CRC initiation and progression remains a central task for investigators. Studies determining the microbial mechanisms that directly contribute to CRC development or progression are revealing bacterial factors such as toxins that contribute to colorectal carcinogenesis. However, even when investigators have identified bacteria that express toxins, questions remain about the host determinants of a toxin's cancer-potentiating effects. For other cancer-correlating bacteria that lack toxins, the challenge is to define cancer-relevant virulence factors. Herein, we evaluate three CRC-correlating bacteria, colibactin-producing Escherichia coli, enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum, for their virulence features relevant to CRC. We also consider the beneficial bioactivity of gut microbes by highlighting a microbial metabolite that may enhance CRC antitumor immunity. In doing so, we aim to elucidate unique and shared mechanisms underlying the microbiota's contributions to CRC and to accelerate investigation from target validation to CRC therapeutic discovery. © 2022, Clay et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License. 
650 0 4 |a animal 
650 0 4 |a Animals 
650 0 4 |a Bacteria 
650 0 4 |a bacterial virulence 
650 0 4 |a bacterium 
650 0 4 |a Bacteroides fragilis 
650 0 4 |a biological activity 
650 0 4 |a carcinogenesis 
650 0 4 |a carcinogenesis 
650 0 4 |a Carcinogenesis 
650 0 4 |a classification 
650 0 4 |a colorectal cancer 
650 0 4 |a Colorectal Neoplasms 
650 0 4 |a colorectal tumor 
650 0 4 |a Escherichia coli 
650 0 4 |a Fusobacterium nucleatum 
650 0 4 |a Gastrointestinal Microbiome 
650 0 4 |a gastrointestinal tract 
650 0 4 |a growth, development and aging 
650 0 4 |a human 
650 0 4 |a Humans 
650 0 4 |a intestine flora 
650 0 4 |a microbiology 
650 0 4 |a microflora 
650 0 4 |a microorganism 
650 0 4 |a mutagenic activity 
650 0 4 |a nonhuman 
650 0 4 |a pathogenicity 
650 0 4 |a Review 
650 0 4 |a toxin 
650 0 4 |a tumor immunity 
650 0 4 |a virulence factor 
700 1 0 |a Clay, S.L.  |e author 
700 1 0 |a Fonseca-Pereira, D.  |e author 
700 1 0 |a Garrett, W.S.  |e author 
773 |t Journal of Clinical Investigation